Aggregation of the synuclein-alpha, SNCA, protein can indicate Parkinson's Disease, PD, symptoms two years prior to diagnosis. Levadopa is a component in synthetic medicines for PD found naturally in plants. I hypothesize that if C. elegans are used as a model, natural levodopa-based medicines could decrease the aggregation of the SNCA protein and the intensity of PD symptoms because of the inversely related correlation between SNCA aggregation and dopamine production.